Evidence map›Paper›PMID 42699336›Full record

ArticleBiochemistry and biophysics reports2026

Optimal autofluorescence blocking for reliable immunofluorescence in human ovarian samples: A comparison of 4 blocking kits.

Rebekka Einenkel-Ulrich, Johanna Schlingheider, Cara Maria Färber, Andreas Schallmoser, Nicole Sänger

Abstract read
In one paragraph

Article in Biochemistry and biophysics reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rebekka Einenkel-UlrichUniversity of Bonn, University Hospital Bonn, Department of Gynecological Endocrinology and Reproductive Medicine, Venusberg-Campus 1, Bonn, 53127, Germany.
Johanna SchlingheiderUniversity of Bonn, University Hospital Bonn, Department of Gynecological Endocrinology and Reproductive Medicine, Venusberg-Campus 1, Bonn, 53127, Germany.
Cara Maria FärberUniversity of Bonn, University Hospital Bonn, Department of Gynecological Endocrinology and Reproductive Medicine, Venusberg-Campus 1, Bonn, 53127, Germany.
Andreas SchallmoserUniversity of Bonn, University Hospital Bonn, Department of Gynecological Endocrinology and Reproductive Medicine, Venusberg-Campus 1, Bonn, 53127, Germany.
Nicole SängerUniversity of Bonn, University Hospital Bonn, Department of Gynecological Endocrinology and Reproductive Medicine, Venusberg-Campus 1, Bonn, 53127, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Fertility depends on the complex process of folliculogenesis, yet many aspects of early human follicle development remain unclear. Immunohistofluorescence (IHF) enables detailed analysis of follicular structures and allows quantification. However, it is often affected by tissue autofluorescence. This study compares four commercially available kits to identify the most effective method for reducing autofluorescence and improving IHF accuracy. Methods: Sections of human ovarian tissue were treated according to the staining protocol without antibodies, but with one of four kits reducing autofluorescence to compare their efficacy. Images were taken on the Ti2-E fluorescence microscope in three different fluorescence channels.The kit with the highest reduction in autofluorescence was applied for a strong and a rather subtle staining in order to analyze the signal-to-background ratio (SBR). Results: All tested reagents reduced tissue autofluorescence in all three fluorescence channels. Among the evaluated products, TrueBlack showed the greatest reduction in autofluorescence. When combined with IHF staining, it significantly reduced background fluorescence and improved the SBR. Nevertheless, TrueVIEW and Ready Probes were similarly effective. Conclusion: Autofluorescence in human ovarian tissue can be effectively reduced using commercially available reagents. Among the tested products, TrueBlack showed the highest efficacy with our specific protocol and setup. Given the high demand for research and the rarity of suitable human ovarian samples, sharing these results may support more accurate and reproducible immunofluorescence analyses in future studies.

Indexed as

Blocking autofluorescenceIL-8ImmunofluorescenceOvaryQuenching autofluorescenceVEGF-A

Identifiers

PMID42699336
PMCPMC13543083

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.